A review of ELTD1, a pro-angiogenic adhesion GPCR
- PMID: 25399586
- DOI: 10.1042/BST20140216
A review of ELTD1, a pro-angiogenic adhesion GPCR
Abstract
Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1), an orphan G-protein-coupled receptor (GPCR) belonging to the adhesion GPCR family, has recently been identified as a potential cancer biomarker and a novel regulator of angiogenesis. In this mini-review, we present an overview of the current literature on ELTD1 and present bioinformatics data showing ELTD1's sequence conservation, its expression in cancer cell lines and its mutational frequency in human cancers. Additionally, we present sequence homology alignment results confirming ELTD1 to be a hybrid comprising motifs shared with individual members in both adhesion GPCR subfamilies 1 and 2. Finally, we discuss why tumour endothelial ELTD1 expression may confer a good prognosis yet still represent a therapeutic target.
Similar articles
-
ELTD1-An Emerging Silent Actor in Cancer Drama Play.Int J Mol Sci. 2021 May 13;22(10):5151. doi: 10.3390/ijms22105151. Int J Mol Sci. 2021. PMID: 34068040 Free PMC article. Review.
-
ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants.BMC Evol Biol. 2019 Jul 12;19(1):143. doi: 10.1186/s12862-019-1445-9. BMC Evol Biol. 2019. PMID: 31299890 Free PMC article.
-
Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system.Stem Cell Res. 2021 May;53:102350. doi: 10.1016/j.scr.2021.102350. Epub 2021 Apr 15. Stem Cell Res. 2021. PMID: 34087984
-
Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling.Sci Rep. 2021 Apr 23;11(1):8870. doi: 10.1038/s41598-021-85408-x. Sci Rep. 2021. PMID: 33893326 Free PMC article.
-
Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.Onco Targets Ther. 2015 Dec 16;8:3767-74. doi: 10.2147/OTT.S93843. eCollection 2015. Onco Targets Ther. 2015. PMID: 26719704 Free PMC article. Review.
Cited by
-
ELTD1-An Emerging Silent Actor in Cancer Drama Play.Int J Mol Sci. 2021 May 13;22(10):5151. doi: 10.3390/ijms22105151. Int J Mol Sci. 2021. PMID: 34068040 Free PMC article. Review.
-
Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):93-109. eCollection 2019. Am J Nucl Med Mol Imaging. 2019. PMID: 30911439 Free PMC article.
-
ELTD1 inhibits differentiation of hemogenic endothelium progenitors from human embryonic stem cells through the HPIP-Wnt pathway.Exp Mol Med. 2025 Jun;57(6):1216-1231. doi: 10.1038/s12276-025-01473-6. Epub 2025 Jun 2. Exp Mol Med. 2025. PMID: 40456828 Free PMC article.
-
ELTD1 Review: New Regulator of Angiogenesis in Glioma.Curr Health Sci J. 2023 Oct-Dec;49(4):495-502. doi: 10.12865/CHSJ.49.04.03. Epub 2023 Dec 29. Curr Health Sci J. 2023. PMID: 38559823 Free PMC article. Review.
-
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.Mol Cancer Res. 2021 Nov;19(11):1957-1969. doi: 10.1158/1541-7786.MCR-21-0171. Epub 2021 Aug 4. Mol Cancer Res. 2021. PMID: 34348993 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous